CleveMed joins Beacon Biosignals
The two companies combine home sleep testing with AI-driven brain monitoring for at-home diagnostics.
See the latest news and media coverage for CleveMed. We track all announcements, press releases, and industry mentions in real time, all in one place.
Home sleep testing solutions provider
clevemed.comLast updated
In short: CleveMed was acquired by Beacon Biosignals and subsequently unified under the Beacon name to expand AI-driven home sleep diagnostics.
The two companies combine home sleep testing with AI-driven brain monitoring for at-home diagnostics.
It enables sleep centers to prescribe mail-order HSAT effortlessly. The service delivers FDA-cleared devices to patients, processes tests at home, and provides AASM-compliant reports quickly.
The investment accelerates AI technologies for brain health, sleep, and CNS diagnostics. CleveMed, its subsidiary, advances sleep testing used in 10,000 monthly studies.
AMA CPT panel approves new home sleep testing codes for 2027, deletes three old codes. AASM collaborated with other societies after years of efforts.
Beacon expands home sleep diagnostics with EEG-enabled testing through Waveband, building on CleveMed's established clinical and operational foundation.BOSTON, June 10, 2026 (GLOBE NEWSWIRE) -- Beacon...
Hitachi Rail agrees to acquire Clever Devices · NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- Hitachi Rail has entered into a definitive agreement to...
Cleveland Medical Devices Inc. (CleveMed) has been awarded a group purchasing agreement for Sleep Diagnostic Services with Premier, Inc. Effective June 1, 2014, the new...
Cleveland Medical Devices has finalized an agreement to license its anesthesia monitoring — its NeuroSense line — and seizure detection technologies through Cleveland Heights, Ohio-based...
Track CleveMed and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to CleveMed and other trending companies.